Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 18,157-18,168 of 23,847
Drug study icon
Active Not RecruitingNCT04523922

Oxytocin to Enhance Integrated Treatment for AUD and PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In Charleston
PTSD, AddictionDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
Medical University of South Carolina
Condition
PTSD, Addiction
Drug study icon
CompletedNCT04228289

Oxytocin to Treat PTSD

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including San Francisco
PTSDDrugOver 18 Years
Countries
United States
Sponsor
VA Office of Research and Development
Condition
PTSD
Drug study icon
WithdrawnNCT03636555

Oxytocin Treatment for Alcohol Use Disorders

This summary needs review. Please check the official study record and contact the research team for details.

In Durham
AddictionDrugFrom 21 Years to 65 Years
Countries
United States
Sponsor
University of North Carolina, Chapel Hill
Condition
Addiction
Drug study icon
CompletedNCT01028677

Oxytocin Treatment of Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Chapel Hill
SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
University of North Carolina, Chapel Hill
Condition
Schizophrenia
Behavioral study icon
CompletedNCT04051619

Oxytocin, Stress, Craving, Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In Providence
AddictionBehavioralFrom 18 Years to 70 Years
Countries
United States
Sponsor
Brown University
Condition
Addiction
Drug study icon
CompletedNCT06973577

P3b Short-term Study of CTN in people with ADHD and Comorbid Anxiety

This study is comparing Centanafadine with placebo for people with Adhd, Anxiety, Generalized Anxiety, or Social anxiety. Participants receive Centanafadine or placebo and complete study visits and assessments.

Multiple locations, including Dothan
Anxiety, ADHDDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Anxiety, ADHD
Other study type icon
CompletedNCT01668355

PACT for Individuals With Serious Mental Illness

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including San Diego
SchizophreniaOtherOver 18 Years
Countries
United States
Sponsor
VA Office of Research and Development
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.